EXAIL TECHNOLOGIES (EXA.PA) Stock Fundamental Analysis
EPA:EXA - FR0000062671 - Common Stock
114.2 EUR
+4 (+3.63%)
EXA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 43 industry peers in the Aerospace & Defense industry. EXA has a bad profitability rating. Also its financial health evaluation is rather negative. EXA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year EXA has reported negative net income.
EXA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EXA reported negative net income in multiple years.
EXA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of EXA (-0.44%) is worse than 76.09% of its industry peers.
EXA has a worse Return On Equity (-3.04%) than 76.09% of its industry peers.
With a Return On Invested Capital value of 2.85%, EXA is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
EXA had an Average Return On Invested Capital over the past 3 years of 2.19%. This is significantly below the industry average of 9.49%.
The last Return On Invested Capital (2.85%) for EXA is above the 3 year average (2.19%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.44% | ||
| ROE | -3.04% | ||
| ROIC | 2.85% |
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
1.3 Margins
EXA has a worse Operating Margin (6.05%) than 67.39% of its industry peers.
EXA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 55.36%, EXA belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
In the last couple of years the Gross Margin of EXA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.05% | ||
| PM (TTM) | N/A | ||
| GM | 55.36% |
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
2. Health
2.1 Basic Checks
EXA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
EXA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, EXA has more shares outstanding
EXA has a worse debt/assets ratio than last year.
2.2 Solvency
EXA has an Altman-Z score of 2.47. This is not the best score and indicates that EXA is in the grey zone with still only limited risk for bankruptcy at the moment.
EXA's Altman-Z score of 2.47 is in line compared to the rest of the industry. EXA outperforms 50.00% of its industry peers.
EXA has a debt to FCF ratio of 6.15. This is a slightly negative value and a sign of low solvency as EXA would need 6.15 years to pay back of all of its debts.
EXA has a Debt to FCF ratio (6.15) which is comparable to the rest of the industry.
A Debt/Equity ratio of 2.52 is on the high side and indicates that EXA has dependencies on debt financing.
With a Debt to Equity ratio value of 2.52, EXA is not doing good in the industry: 82.61% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.52 | ||
| Debt/FCF | 6.15 | ||
| Altman-Z | 2.47 |
ROIC/WACC0.38
WACC7.41%
2.3 Liquidity
A Current Ratio of 1.25 indicates that EXA should not have too much problems paying its short term obligations.
The Current ratio of EXA (1.25) is better than 63.04% of its industry peers.
A Quick Ratio of 0.93 indicates that EXA may have some problems paying its short term obligations.
EXA has a better Quick ratio (0.93) than 73.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
The earnings per share for EXA have decreased strongly by -128.05% in the last year.
Looking at the last year, EXA shows a quite strong growth in Revenue. The Revenue has grown by 15.32% in the last year.
EXA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.32% yearly.
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%
3.2 Future
EXA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 88.61% yearly.
The Revenue is expected to grow by 14.26% on average over the next years. This is quite good.
EPS Next Y1245.33%
EPS Next 2Y474.75%
EPS Next 3Y266.9%
EPS Next 5Y88.61%
Revenue Next Year24.12%
Revenue Next 2Y23.5%
Revenue Next 3Y21.93%
Revenue Next 5Y14.26%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
EXA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 132.71, EXA can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, EXA is valued more expensive than 84.78% of the companies in the same industry.
EXA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 132.71 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXA indicates a somewhat cheap valuation: EXA is cheaper than 65.22% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.09 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXA's earnings are expected to grow with 266.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y474.75%
EPS Next 3Y266.9%
5. Dividend
5.1 Amount
No dividends for EXA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:EXA (8/29/2025, 7:00:00 PM)
114.2
+4 (+3.63%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners20.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.99B
Analysts84
Price Target110.84 (-2.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.02
Dividend Growth(5Y)-41.67%
DP-10.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)21.85%
PT rev (3m)132.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.29%
EPS NY rev (3m)-2.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.74%
Revenue NY rev (3m)3.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 132.71 | ||
| P/S | 5.33 | ||
| P/FCF | 35.09 | ||
| P/OCF | 21.77 | ||
| P/B | 16.59 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.21
EYN/A
EPS(NY)0.86
Fwd EY0.75%
FCF(TTM)3.25
FCFY2.85%
OCF(TTM)5.25
OCFY4.59%
SpS21.42
BVpS6.88
TBVpS-17.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.44% | ||
| ROE | -3.04% | ||
| ROCE | 3.88% | ||
| ROIC | 2.85% | ||
| ROICexc | 3.14% | ||
| ROICexgc | 14.88% | ||
| OM | 6.05% | ||
| PM (TTM) | N/A | ||
| GM | 55.36% | ||
| FCFM | 15.2% |
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
ROICexc(3y)2.4%
ROICexc(5y)3.68%
ROICexgc(3y)9.45%
ROICexgc(5y)12.41%
ROCE(3y)2.98%
ROCE(5y)3.95%
ROICexcg growth 3Y18.91%
ROICexcg growth 5Y18.06%
ROICexc growth 3Y-17.84%
ROICexc growth 5Y1.29%
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
F-Score5
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.52 | ||
| Debt/FCF | 6.15 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 1.55 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | 2.47 |
F-Score5
WACC7.41%
ROIC/WACC0.38
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.56%
Cap/Sales(5y)12.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
EPS Next Y1245.33%
EPS Next 2Y474.75%
EPS Next 3Y266.9%
EPS Next 5Y88.61%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%
Revenue Next Year24.12%
Revenue Next 2Y23.5%
Revenue Next 3Y21.93%
Revenue Next 5Y14.26%
EBIT growth 1Y1338.9%
EBIT growth 3Y22.08%
EBIT growth 5Y23.35%
EBIT Next Year179.27%
EBIT Next 3Y66.38%
EBIT Next 5Y43.35%
FCF growth 1Y137.85%
FCF growth 3YN/A
FCF growth 5Y40.49%
OCF growth 1Y64.25%
OCF growth 3YN/A
OCF growth 5Y26.69%